US Stock MarketDetailed Quotes

CGEM Cullinan Therapeutics

Watchlist
  • 11.600
  • +0.650+5.94%
Close Dec 20 16:00 ET
  • 11.600
  • 0.0000.00%
Post 17:22 ET
675.44MMarket Cap-4.08P/E (TTM)

Cullinan Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
0.01%-34.14M
-17.05%-36.29M
25.00%-38.25M
-6.01%-134.28M
27.43%-18.13M
37.19%-34.14M
-21.97%-31.01M
-132.78%-51M
-191.63%-126.66M
-64.68%-24.98M
Net income from continuing operations
-3.51%-40.56M
-30.47%-42.03M
35.78%-37.34M
-242.04%-155.1M
5.63%-25.56M
-57.42%-39.18M
-118.51%-32.21M
-350.99%-58.14M
261.81%109.2M
20.81%-27.09M
Operating gains losses
----
----
----
----
----
----
----
----
---276.75M
---91K
Depreciation and amortization
-5.00%76K
-4.94%77K
5.56%76K
233.33%310K
30.51%77K
788.89%80K
575.00%81K
453.85%72K
75.47%93K
391.67%59K
Other non cash items
----
----
----
-64.97%131K
-45.96%127K
--0
--0
--4K
458.21%374K
--235K
Change In working capital
1,117.68%1.84M
75.30%-1.15M
-600.34%-5.9M
-103.03%-339K
166.05%3.31M
99.48%-181K
-109.67%-4.65M
-61.03%1.18M
415.62%11.18M
-187.10%-5.01M
-Change in prepaid assets
135.27%1.34M
-235.28%-2.59M
154.44%411K
-426.02%-5.94M
-428.73%-3.29M
-801.84%-3.81M
2,028.89%1.92M
33.77%-755K
65.43%-1.13M
-133.95%-623K
-Change in payables and accrued expense
-86.28%498K
122.00%1.44M
-426.36%-6.32M
-54.45%5.61M
250.50%6.6M
110.24%3.63M
-113.68%-6.56M
-53.57%1.94M
4,624.26%12.31M
-212.00%-4.39M
Cash from discontinued investing activities
Operating cash flow
0.01%-34.14M
-17.05%-36.29M
25.00%-38.25M
-6.01%-134.28M
27.43%-18.13M
37.19%-34.14M
-21.97%-31.01M
-132.78%-51M
-191.63%-126.66M
-64.68%-24.98M
Investing cash flow
Cash flow from continuing investing activities
146.27%19.88M
-1,628.59%-185.11M
-14.67%12.96M
-85.62%35.81M
279.90%51.47M
25.91%-42.96M
-95.97%12.11M
-56.26%15.18M
174.59%248.98M
-80.37%-28.61M
Net PPE purchase and sale
--0
--0
--0
80.04%-208K
--0
--0
---49K
---159K
---1.04M
---791K
Net business purchase and sale
----
----
----
--0
----
----
----
----
--275M
--0
Net investment purchase and sale
146.27%19.88M
-1,622.43%-185.11M
-15.56%12.96M
244.15%36.01M
285.02%51.47M
31.52%-42.96M
-60.59%12.16M
-55.80%15.34M
92.52%-24.98M
-75.38%-27.82M
Cash from discontinued investing activities
Investing cash flow
146.27%19.88M
-1,628.59%-185.11M
-14.67%12.96M
-85.62%35.81M
279.90%51.47M
25.91%-42.96M
-95.97%12.11M
-56.26%15.18M
174.59%248.98M
-80.37%-28.61M
Financing cash flow
Cash flow from continuing financing activities
1,083.04%1.33M
579.23%262.2M
-39.35%1.09M
257.14%40.75M
100.75%248K
-92.14%112K
1,817.64%38.6M
-49.48%1.79M
-109.65%-25.93M
-1,318.06%-32.91M
Net issuance payments of debt
--0
--0
--0
942.86%1.83M
--0
--0
--0
128.13%1.83M
--175K
--175K
Net common stock issuance
--0
----
----
--38.39M
--0
--0
----
----
--0
--0
Proceeds from stock option exercised by employees
1,668.75%1.98M
1,458.88%3.34M
3,113.89%1.09M
-91.06%538K
27.84%248K
-92.14%112K
-92.39%214K
-102.27%-36K
83.48%6.02M
-92.82%194K
Net other financing activities
---656K
----
----
----
----
----
----
----
-1,720.28%-32.13M
---33.28M
Cash from discontinued financing activities
Financing cash flow
1,083.04%1.33M
579.23%262.2M
-39.35%1.09M
257.14%40.75M
100.75%248K
-92.14%112K
1,817.64%38.6M
-49.48%1.79M
-109.65%-25.93M
-1,318.06%-32.91M
Net cash flow
Beginning cash position
-18.90%115.02M
-39.22%74.23M
-36.96%98.43M
161.24%156.15M
-73.28%64.85M
-59.88%141.83M
60.45%122.13M
161.24%156.15M
-64.46%59.77M
175.42%242.66M
Current changes in cash
83.20%-12.94M
107.01%40.79M
28.86%-24.21M
-159.89%-57.72M
138.83%33.59M
30.58%-76.99M
-92.90%19.71M
-308.17%-34.02M
188.89%96.38M
-205.34%-86.51M
End cash Position
57.42%102.09M
-18.90%115.02M
-39.22%74.23M
-36.96%98.43M
-36.96%98.43M
-73.28%64.85M
-59.88%141.83M
60.45%122.13M
161.24%156.15M
161.24%156.15M
Free cash flow
0.01%-34.14M
-16.86%-36.29M
25.23%-38.25M
-5.23%-134.48M
29.90%-18.13M
37.48%-34.14M
-22.17%-31.06M
-133.50%-51.16M
-194.24%-127.8M
-70.49%-25.87M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 0.01%-34.14M-17.05%-36.29M25.00%-38.25M-6.01%-134.28M27.43%-18.13M37.19%-34.14M-21.97%-31.01M-132.78%-51M-191.63%-126.66M-64.68%-24.98M
Net income from continuing operations -3.51%-40.56M-30.47%-42.03M35.78%-37.34M-242.04%-155.1M5.63%-25.56M-57.42%-39.18M-118.51%-32.21M-350.99%-58.14M261.81%109.2M20.81%-27.09M
Operating gains losses -----------------------------------276.75M---91K
Depreciation and amortization -5.00%76K-4.94%77K5.56%76K233.33%310K30.51%77K788.89%80K575.00%81K453.85%72K75.47%93K391.67%59K
Other non cash items -------------64.97%131K-45.96%127K--0--0--4K458.21%374K--235K
Change In working capital 1,117.68%1.84M75.30%-1.15M-600.34%-5.9M-103.03%-339K166.05%3.31M99.48%-181K-109.67%-4.65M-61.03%1.18M415.62%11.18M-187.10%-5.01M
-Change in prepaid assets 135.27%1.34M-235.28%-2.59M154.44%411K-426.02%-5.94M-428.73%-3.29M-801.84%-3.81M2,028.89%1.92M33.77%-755K65.43%-1.13M-133.95%-623K
-Change in payables and accrued expense -86.28%498K122.00%1.44M-426.36%-6.32M-54.45%5.61M250.50%6.6M110.24%3.63M-113.68%-6.56M-53.57%1.94M4,624.26%12.31M-212.00%-4.39M
Cash from discontinued investing activities
Operating cash flow 0.01%-34.14M-17.05%-36.29M25.00%-38.25M-6.01%-134.28M27.43%-18.13M37.19%-34.14M-21.97%-31.01M-132.78%-51M-191.63%-126.66M-64.68%-24.98M
Investing cash flow
Cash flow from continuing investing activities 146.27%19.88M-1,628.59%-185.11M-14.67%12.96M-85.62%35.81M279.90%51.47M25.91%-42.96M-95.97%12.11M-56.26%15.18M174.59%248.98M-80.37%-28.61M
Net PPE purchase and sale --0--0--080.04%-208K--0--0---49K---159K---1.04M---791K
Net business purchase and sale --------------0------------------275M--0
Net investment purchase and sale 146.27%19.88M-1,622.43%-185.11M-15.56%12.96M244.15%36.01M285.02%51.47M31.52%-42.96M-60.59%12.16M-55.80%15.34M92.52%-24.98M-75.38%-27.82M
Cash from discontinued investing activities
Investing cash flow 146.27%19.88M-1,628.59%-185.11M-14.67%12.96M-85.62%35.81M279.90%51.47M25.91%-42.96M-95.97%12.11M-56.26%15.18M174.59%248.98M-80.37%-28.61M
Financing cash flow
Cash flow from continuing financing activities 1,083.04%1.33M579.23%262.2M-39.35%1.09M257.14%40.75M100.75%248K-92.14%112K1,817.64%38.6M-49.48%1.79M-109.65%-25.93M-1,318.06%-32.91M
Net issuance payments of debt --0--0--0942.86%1.83M--0--0--0128.13%1.83M--175K--175K
Net common stock issuance --0----------38.39M--0--0----------0--0
Proceeds from stock option exercised by employees 1,668.75%1.98M1,458.88%3.34M3,113.89%1.09M-91.06%538K27.84%248K-92.14%112K-92.39%214K-102.27%-36K83.48%6.02M-92.82%194K
Net other financing activities ---656K-----------------------------1,720.28%-32.13M---33.28M
Cash from discontinued financing activities
Financing cash flow 1,083.04%1.33M579.23%262.2M-39.35%1.09M257.14%40.75M100.75%248K-92.14%112K1,817.64%38.6M-49.48%1.79M-109.65%-25.93M-1,318.06%-32.91M
Net cash flow
Beginning cash position -18.90%115.02M-39.22%74.23M-36.96%98.43M161.24%156.15M-73.28%64.85M-59.88%141.83M60.45%122.13M161.24%156.15M-64.46%59.77M175.42%242.66M
Current changes in cash 83.20%-12.94M107.01%40.79M28.86%-24.21M-159.89%-57.72M138.83%33.59M30.58%-76.99M-92.90%19.71M-308.17%-34.02M188.89%96.38M-205.34%-86.51M
End cash Position 57.42%102.09M-18.90%115.02M-39.22%74.23M-36.96%98.43M-36.96%98.43M-73.28%64.85M-59.88%141.83M60.45%122.13M161.24%156.15M161.24%156.15M
Free cash flow 0.01%-34.14M-16.86%-36.29M25.23%-38.25M-5.23%-134.48M29.90%-18.13M37.48%-34.14M-22.17%-31.06M-133.50%-51.16M-194.24%-127.8M-70.49%-25.87M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Heat List
US
Overall
Symbol
Price
% Chg

No Data